Scleredema and diabetic sclerodactyly

Dermatology Online Journal

Volumn 11, Issue 4, 2005, Pages

  Gruson, Lisa Moed ^a   Franks Jr , Andrew ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MUCIN;

ADULT; ANAMNESIS; ARTICLE; BACK; CASE REPORT; CHILDHOOD; CLINICAL FEATURE; CONNECTIVE TISSUE; DERMIS; DIABETIC SCLERODACTYLY; DISEASE COURSE; DISEASE DURATION; HAND; HARDNESS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; SCLEREDEMA; SKIN BIOPSY; SKIN DISEASE; THICKNESS;

EID: 30144443992     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ferringer T, Miller OF. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 2002;20:483
2. Yosipovitch G, et al. Medical pearl: scleroderma-like skin changes in patients with diabetes mellitus. J Am Acad Dermatol 2003;48:109
3. Bub JL, Olerud JE. Diabetes mellitus. In Freedberg IM, et al., editors. Dermatology in General Medicine. New York: McGraw-Hill;2003:1651
4. Tuzun B, et al. Diabetic sclerodactyly. Diabetes Res Clin Pract 1995;27:153
5. Wilson BE, Newmark JJ. Severe scleredema diabeticorum and insulin resistance. J Am Board Fam Pract 1995;8:55
6. Maize J, Metcalf J. Metabolic diseases of the skin. In Elder D, et al, editors. Lever's Histopathology of the Skin. Philadelphia: Lippincott, Williams and Wilkins;1997:369
7. Haustein UF. Scleroderma-like lesions in insulin-dependent diabetes mellitus. J Eur Acad Dermatol Venereol 1999;13:50
8. Mosby's drug consult on MD Consult. http://www.mdconsult.com
9. Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol 2002;138:99
10. Lin AT, et al. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis. Rheum Dis Clin N Am 2003;29:409
11. Janiga JJ, et al. UVA-1 as a treatment for scleredema. Photodermatol Photoimmunol Photomed 2004;20:210